Twelve months after two 16 mg doses of the drug, called CYB003, seven patients saw their scores improve on the ...

Antidepressant side effects may not universally improve as treatment progresses, a new study published in Acta Psychiatrica ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help ...

Fampridine, used for improving walking in multiple sclerosis, may also enhance working memory in individuals with schizophrenia or depression.

Depression is a complex mental health disorder caused by various factors, including genetics, environment, and lifestyle. By ...

Phase II results for Cybin’s psilocin therapy showed remission rates of 71%, but just eight patients made it to the 12-month ...

“She said she was approaching forty. I couldn’t help wondering from what direction.” ...

Endo, Inc. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its ...

Former President Bill Clinton talks about how philanthropy has allowed him to continue making changes in the world to help ...

Screen time is more than just hours spent on devices. By studying diverse digital habits, researchers can help people adopt a ...